Thomas Pfister

Title: Thomas Pfister: Innovator in Parenteral Bisphosphonate Composition

Introduction

Thomas Pfister is a notable inventor based in Sissach, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bisphosphonate compositions. His work focuses on improving the local tolerance of these compositions when administered parenterally.

Latest Patents

Thomas Pfister holds a patent for a "Parenteral bisphosphonate composition with improved local tolerance." This invention relates to a parenteral composition that includes a bisphosphonic acid or a pharmaceutically acceptable salt thereof as the active component, along with a pharmaceutically acceptable chelating agent. The patent outlines processes for preparing this composition and methods for its use in treating and preventing diseases associated with bone resorption, such as osteoporosis, Paget's disease, hypercalcemia of malignancy, and metabolic bone disease. The compositions are particularly beneficial for enhancing the local tolerance of the active component during parenteral administration.

Career Highlights

Throughout his career, Thomas Pfister has been associated with Hoffmann-La Roche Inc., a leading global healthcare company. His innovative work in the pharmaceutical sector has contributed to advancements in treatment options for patients suffering from various bone-related conditions.

Collaborations

Thomas has collaborated with esteemed colleagues, including Anke Diederich and Pierre Goldbach. Their combined expertise has furthered research and development in the field of bisphosphonate therapies.

Conclusion

Thomas Pfister's contributions to the pharmaceutical industry, particularly through his patent on bisphosphonate compositions, highlight his role as an innovator in improving patient care. His work continues to influence the treatment of bone resorption diseases, showcasing the importance of innovation in healthcare.